Matthew Griffin
@mattgriffinneph
Followers
201
Following
3
Media
0
Statuses
27
An academic nephrologist interested in transplantation, immunology, regenerative medicine, diabetic kidney disease and postgraduate education among other things
Galway, Ireland
Joined January 2017
Progress toward the clinical application of mesenchymal stromal cells and other disease-modulating regenerative therapies https://t.co/bz8CtfPZzM In this open access paper, we review exciting developments in regenerative therapies for kidney diseases.
0
1
6
Looking forward to seeing up-to-date nephrology and transplant COVID19 experiences from around the world.
I established #COVID19Kidney for medical staff, researchers to collaborate, monitor, share knowledge on impact of the COVID-19 pandemic on Nephrology /Hypertension practice & generate research questions in the search for treatment and improve understanding in Neph community.
0
1
3
Our expert group from the EU FP7 consortium VISICORT review recent progress and future research opportunities in high risk corneal transplantation.
With the unique immunological basis of #cornea transplants, Armitage et al encourage focus on translational medicine to ultimately improve graft survival. https://t.co/2mQEYTgYSW
0
4
10
Prof Dr Uwe Pleyer, Charité presents VISICORT at IOIS 2019 meeting in Taiwan
0
0
0
The VISICORT Consortium expert review on high risk corneal transplantation is available as an Open Access article on the Transplantation website. High-Risk Corneal Transplantation: Recent Developments and... : Transplantation
0
0
1
Effects of Arteriovenous Fistula Ligation on Cardiac Structure and Function in Kidney Transplant Recipients | Circulation
ahajournals.org
Background: Cardiovascular morbidity and mortality remain high in recipients of a kidney transplant. The persistence of a patent arteriovenous fistula (AVF) after transplantation may contribute to...
0
0
0
Japan's health ministry approves world's first trials for using iPS cells to treat corneal disease | The Japan Times
0
1
0
VISICORT Clinical Trial is now fully approved and ready for launch!
2
4
20
Our latest publication!
Third-Party Allogeneic Mesenchymal Stromal Cells Prevent Rejection in a Pre-sensitized High-Risk Model of Corneal Transplantation. https://t.co/aVOw09ltLp
0
5
7
VISICORT will profile data from 700 CORNEAL TRANSPLANT RECIPIENTS from 5 leading laboratories to ultimately improve corneal transplant success. https://t.co/p0xGhLOJwg
0
4
3
Thought-provoking NEJM review on academic/industry/foundation partnerships for accelerating clinical translation:
0
2
0
VISICORT Three-year Plenary Meeting held in Edinburgh
0
0
1
It was great to see all the team at our recent plenary at NUI Galway. Excellent progress being made - see nephstrom.eu for all the news.
0
2
2
Kidney Donation, How Safe Is It? The ERA-EDTA Descartes Working Group Position
nephjc.com
Chat on Tuesday and Wednesday April 11 and 12. EDTA Descartes Work Group white paper on the risk of kidney donation.
1
17
18
Expect a bump in creatinine after ACE inhibitor? Lovely population based study looking at impact of this: https://t.co/L2v4wxaVJA
1
1
1
Growth Differentiation Factor–15 and Risk of #CKD Progression https://t.co/0KAzdueiR9
@KidneyResInst
0
2
5
Nursing and Health Sciences: Petition re. the Post of President and the Irish language - Sign the Pet... https://t.co/V4vnQyxDk9 via @Change
0
0
1
Hadn't appreciated the level of quality clinical #nephrology research by @smyth_andrew in @nuigalway #hrbghconf17
1
2
2